This inventor holds 1 USPTO granted patent. Top assignee: Eyegene Inc.. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Innovations by Kyung Sul Kim in Retinopathy Treatment
Introduction
Kyung Sul Kim is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of medical treatments, particularly in addressing eye conditions such as retinopathy and glaucoma. His innovative work has led to the development of a unique composition that utilizes thrombin-derived peptides.
Latest Patents
Kyung Sul Kim holds 1 patent for his invention titled "Composition for treating retinopathy or glaucoma comprising thrombin derived peptides." This patent discloses a composition that effectively treats retinopathy by incorporating thrombin-derived peptides as a key component.
Career Highlights
Currently, Kyung Sul Kim is associated with Eyegene Inc., a company focused on advancing medical technologies. His role at Eyegene Inc. allows him to further his research and development efforts in the field of ophthalmology.
Collaborations
Throughout his career, Kyung Sul Kim has collaborated with esteemed colleagues, including Jin Wook Jang and Hyeong Joon Lim. These partnerships have contributed to the advancement of innovative solutions in eye care.
Conclusion
Kyung Sul Kim's work exemplifies the impact of innovation in medical treatments, particularly for eye diseases. His contributions continue to pave the way for new therapeutic options in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile